These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007 [TBL] [Abstract][Full Text] [Related]
4. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Dasgupta B; Li W; Perry A; Gutmann DH Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300 [TBL] [Abstract][Full Text] [Related]
5. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice. Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533 [TBL] [Abstract][Full Text] [Related]
6. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging. Su W; Xing R; Guha A; Gutmann DH; Sherman LS Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023 [TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth. Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233 [TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
12. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1. Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258 [TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth. Simmons GW; Pong WW; Emnett RJ; White CR; Gianino SM; Rodriguez FJ; Gutmann DH J Neuropathol Exp Neurol; 2011 Jan; 70(1):51-62. PubMed ID: 21157378 [TBL] [Abstract][Full Text] [Related]
14. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice. Wu M; Wallace MR; Muir D J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234 [TBL] [Abstract][Full Text] [Related]
15. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation. Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma. Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672 [TBL] [Abstract][Full Text] [Related]
17. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma. Solga AC; Gianino SM; Gutmann DH Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450 [TBL] [Abstract][Full Text] [Related]
18. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1. Freret ME; Gutmann DH J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429 [TBL] [Abstract][Full Text] [Related]
19. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Silva AJ; Frankland PW; Marowitz Z; Friedman E; Laszlo GS; Cioffi D; Jacks T; Bourtchuladze R Nat Genet; 1997 Mar; 15(3):281-4. PubMed ID: 9054942 [TBL] [Abstract][Full Text] [Related]